Addnode Group AB (publ) (ANOD-B)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 64.60 |
|---|---|
| 52-week range | 30.95 – 116.40 |
| Return, 1 month / 3 months | +30.8% / +69.1% |
| Return, 1 year / 3 years | −41.6% / −3.7% |
| Trend | Uptrend |
| RSI (14) | 79 |
| Volatility (1 year) | 50.8% |
| Worst drawdown (1 year) | -68.5% |
| Average daily value traded | 26.75M SEK |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Addnode Group is a Swedish software company that acquires and develops businesses providing digital products and services. Its subsidiaries supply design and engineering software, product lifecycle management tools and information management systems to customers in architecture, engineering, construction, manufacturing and property management. The company is based in Stockholm and operates through a group of specialist businesses serving clients across Europe and other markets, helping organisations manage technical information and digital workflows.
On this site Addnode Group AB (publ) appears as a stock on the Nasdaq Stockholm (Sweden), code ANOD-B, with prices in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Addnode Group AB (publ) (ANOD-B) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 64.60 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 456 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 41.6% and over the last three months it rose 69.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 17.0% | ||
| From 52-week high | -43.0% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 69.1% | ||
| 6-month return | -8.1% | ||
| 12-month return, skipping the last month | -55.4% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 50.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -68.5% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 26.75M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 45 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +13.7% |
|---|---|
| 1 month | +30.8% |
| 3 months | +69.1% |
| 6 months | −8.1% |
| 1 year | −41.6% |
| 3 years | −3.7% |
| 5 years | −20.8% |
Signals
| 50-day / 200-day average | 50.35 / 55.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.23 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | SEK 1.1500 |
| 8 May 2025 | SEK 1.1500 |
| 8 May 2024 | SEK 1.0000 |
| 5 May 2023 | SEK 1.0000 |
| 5 May 2022 | SEK 3.0000 |
| 7 May 2021 | SEK 2.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.